Codon Capital targets $50m for inaugural fund

Codon Capital is seeking to raise $50 million for its maiden fund, according to an SEC filing.

Codon Capital is seeking to raise $50 million for its maiden fund, according to an SEC filing. Codon Capital is a San Francisco-based biotech venture firm, specializing in therapeutics and synthetic biology.

Source: SEC filing